Press Release: Ovid Therapeutics and Ligand Pharmaceuticals Enter Into a $30 Million Agreement for a 13% Interest in Soticlestat Royalties and Milestones Extending Ovid's Cash Runway Into 2026
Press Release: Ovid Therapeutics and Ligand Pharmaceuticals Enter Into a $30 Million Agreement for a 13% Interest in Soticlestat Royalties and Milestones Extending Ovid's Cash Runway Into 2026
新闻发布：ovid therapeutics和ligand pharmaceuticals签署了一项3000万美元的协议，以获得Soticlestat版税和里程碑的13％利息，将ovid的现金流延长到2026年。
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登录免费看全文
登录/注册